CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Certified by Founder
Lodge
DeepCure
start up
United States
- Boston, MA
- 08/11/2021
- Series A
- $40,000,000
DeepCure was founded to accelerate breakthrough science, developed by world-leading AI engineers, data scientists and biologists.
Our founding team includes some of the industry’s preeminent drug-discovery scientists and technologists.
Our vision is to use AI-driven discovery to create better molecules and faster cures for every disease-relevant protein target.
- Industry Biotechnology Research
- Website https://deepcure.ai/
- LinkedIn https://www.linkedin.com/company/deepcure/about/
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)